T0	Disease 38 40	PE
#1	AnnotatorNotes T0	DOID:10591
T1	Biomarker 84 99	FAO dysfunction
T10	Biomarker 354 394	fatty infiltration of liver and placenta
T12	Chemical 425 438	triglycerides
T14	Disease 550 552	PE
T15	Disease 557 574	liver dysfunction
#7	AnnotatorNotes T15	D008107
T18	Chemical 732 744	triglyceride
T19	Disease 770 772	PE
T2	Biomarker 105 118	FAO disorders
T23	Chemical 853 883	lipid peroxide malondialdehyde
T24	Disease 932 945	FAO disorders
T25	Gene-Protein 975 980	LCHAD
T26	Chemical 1034 1045	fatty acids
T27	Biomarker 1080 1102	fetal LCHAD deficiency
T30	Disease 1129 1155	maternal acute fatty liver
T32	Disease 1159 1173	HELLP syndrome
#21	AnnotatorNotes T32	DOID:13133
T34	Gene-Protein 1257 1262	LCHAD
T35	Disease 1290 1292	PE
T37	Gene-Protein 1350 1355	LCHAD
T38	Disease 1385 1405	PE with liver damage
T4	Disease 157 159	PE
T40	Disease 1519 1521	PE
T41	Biomarker 1542 1555	FAO disorders
T5	Disease 219 249	acute fatty liver of pregnancy
#31	AnnotatorNotes T5	C537957
T6	Disease 254 263	hemolysis
T8	Disease 292 321	low platelet (HELLP) syndrome
T9	Disease 350 352	PE
R1	Association Arg1:T1 Arg2:T0	
R2	Association Arg1:T2 Arg2:T7	
#2	AnnotatorNotes T6	D006461
T3	Biomarker 265 287	elevated liver enzymes
#4	AnnotatorNotes T8	DOID:13133
T7	Collection 157 263	PE and were closely related to pathological pregnancy such as acute fatty liver of pregnancy and hemolysis
R3	Association Arg1:T2 Arg2:T8	
T11	Biomarker 399 446	increased levels of serum triglycerides and FFA
T16	Collection 354 446	fatty infiltration of liver and placenta and increased levels of serum triglycerides and FFA
R4	Association Arg1:T16 Arg2:T9	
T13	Collection 550 574	PE and liver dysfunction
T17	Biomarker 584 634	various degrees of fatty disposition in the livers
R5	Association Arg1:T17 Arg2:T13	
T20	Biomarker 716 752	serum levels of triglyceride and FFA
R6	Association Arg1:T20 Arg2:T19	
T28	Biomarker 805 883	positively correlated with the concentration of lipid peroxide malondialdehyde
#3	AnnotatorNotes T25	HGNC:4801
#5	AnnotatorNotes T24	not found
T21	Biomarker 975 980	LCHAD
R7	Association Arg1:T21 Arg2:T24	
#6	AnnotatorNotes T30	C537957
T22	Collection 1129 1173	maternal acute fatty liver or HELLP syndrome
R8	Association Arg1:T27 Arg2:T22	
T29	Biomarker 1234 1267	abnormal expression of LCHAD gene
R9	Association Arg1:T29 Arg2:T35	
T31	Biomarker 1326 1381	placental expression of LCHAD was significantly reduced
#8	AnnotatorNotes T38	DOID:10591, not found
A1	Conjunction T38
R10	Association Arg1:T31 Arg2:T38	
R11	Association Arg1:T41 Arg2:T40	
T33	Disease 1708 1717	L-NAME PE
T36	Biomarker 1586 1602	lipid deposition
T39	Biomarker 1607 1670	decreased protein expression of LCHAD in the liver and placenta
T42	Gene-Protein 1639 1644	LCHAD
T43	Biomarker 1675 1700	elevated serum FFA levels
T44	Collection 1586 1700	lipid deposition and decreased protein expression of LCHAD in the liver and placenta and elevated serum FFA levels
R12	Association Arg1:T44 Arg2:T33	
T45	Chemical 1690 1693	FFA
T46	Gene-Protein 1086 1091	LCHAD
#9	AnnotatorNotes T33	not found
T47	Chemical 1708 1714	L-NAME
